SEC 13F Intelligence

Orion Investment Co / 2655787D

Orion Investment Co’s Blueprint Medicines Position

Does Orion Investment Co own Blueprint Medicines (2655787D)? Not currently — the last reported position was 106.1K shares worth $14M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$14M
Q2 2025
Shares
106.1K
% of Portfolio
+4.82%
Quarters Held
5
position exited

Position History 2655787D

Reported value by quarter
Q2 ’24: $12MQ2 ’24Q3 ’24: $10MQ3 ’24Q4 ’24: $9MQ4 ’24Q1 ’25: $10MQ1 ’25Q2 ’25: $14MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025106.1K$14M+4.82%
Q1 2025109.0K$10M+3.95%
Q4 2024108.7K$9M+3.78%
Q3 2024108.6K$10M+3.91%
Q2 2024108.8K$12M+4.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orion Investment Co’s full portfolio or all institutional holders of 2655787D.